Brief: Circio: In Vivo Proof-Of-Concept For Circvec Circular RNA Platform Technology
April 17 (Reuters) - Circio Holding ASA CRNA.OL :
* CIRCIO ANNOUNCES IN VIVO PROOF-OF-CONCEPT FOR ITS CIRCVEC
CIRCULAR RNA PLATFORM TECHNOLOGY AND REINFORCED GENE THERAPY
FOCUS
Source text for Eikon: ID:nObiHVJSRa
Further company coverage: CRNA.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration